Protective Effect of N-acetylcysteine Against From Ototoxicity
Launched by TC ERCIYES UNIVERSITY · Jan 5, 2011
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
NAC, a thiol-containing antioxidant because of this,we want to investigate antioxidant status.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • End-stage renal disease
- • Undergoing continuous ambulatory peritoneal dialysis as a renal replacement therapy
- • Developing the first continuous ambulatory peritoneal dialysis related peritonitis episode
- Exclusion Criteria:
- • Being treated with aminoglycoside antibiotics and vancomycine within the previous 3 months
- • Detection of mechanical occlusion of external ear
- • Having signs of disturbed integrity of tympanic membrane on otoscopy or tympanometry
- • History of a continuous ambulatory peritoneal dialysis related peritonitis
About Tc Erciyes University
TC Erciyes University is a leading academic institution in Turkey, dedicated to advancing medical research and healthcare through innovative clinical trials. With a strong emphasis on scientific excellence and collaboration, the university leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies aimed at improving patient outcomes. Committed to ethical standards and regulatory compliance, TC Erciyes University fosters a research environment that promotes the development of new therapies and interventions, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kayseri, , Turkey
Patients applied
Trial Officials
Ismail Kocyigit, MD
Principal Investigator
TC Erciyes University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials